Skip to main content
. 2021 Feb 9;14:491–501. doi: 10.2147/RMHP.S285880

Table 3.

Comparison of the Characteristics Between Different Subtypes with Single Risk

Variables Obesity-Only MD-Only Diabetes-Only P Among Three Groups P P P
Obesity vs MD Obesity vs Diabetes Diabetes vs MD
N 735 384 46
Age (years) 39.6±13.69 44.42±16.37 52.48±14.84 <0.001 <0.001 <0.001 0.001
Male (%) 394 (53.61) 192 (50) 31 (67.39) 0.070 0.279 0.095 0.038
BMI (Kg/m2) 30.46±4.86 22.27±2.07 22.07±2.26 <0.001 <0.001 <0.001 0.567
Diabetes (%) 0 (0) 0 (0) 46 (100) <0.001 1.000 <0.001 <0.001
Hypertension (%) 61 (8.30) 104 (27.08) 5 (10.87) <0.001 <0.001 0.580 0.027
Hepatic steatosis (%) 0.151 0.174 0.278 0.113
 Mild 321 (43.67) 190 (49.48) 18 (39.13)
 Moderate 290 (39.46) 138 (35.94) 16 (34.78)
 Severe 124 (16.87) 56 (14.58) 12 (26.09)
Previous diagnosis 0.014 0.006 0.965 0.282
 NAFLD 645 (87.76) 313 (81.51) 41 (89.13)
 Alcoholic or viral hepatitis 90 (12.24) 71 (18.49) 5 (10.87)
Alcohol (g/Week) 62.39±131.15 69.81±171.3 87.73±234.38 0.444 0.458 0.471 0.617
Overdrink (%) 70 (9.52) 46 (11.98) 5 (10.87) 0.425 0.240 0.795 1.000
Platelets (×109/L) 279.26±68.91 277.65±73.20 254.36±90.91 0.072 0.723 0.074 0.100
BUN (mmol/L) 4.68±1.52 4.69±1.71 5.2±2.34 0.106 0.942 0.143 0.156
Uric acid (μmol/L) 331.04±83.83 309.16±92.69 299.72±76.22 <0.001 <0.001 0.01 0.442
Creatinine (μmol/L) 92.11±17.01 91.74±19.62 99.17±42.81 0.048 0.751 0.272 0.251
GFR (mL/min) 84.82±17.82 81.82±18.92 80.22±22.07 0.015 0.010 0.172 0.639
TBIL (μmol/L) 10.17±5.76 10.03±6.97 9.89±4.23 0.905 0.734 0.667 0.841
ALT (U/L) 24.08±20.85 19.68±18.91 22.07±20.98 0.003 <0.001 0.530 0.466
AST (U/L) 25.57±21.54 24.48±14.10 27.65±22.51 0.475 0.311 0.544 0.355
GGT (U/L) 38.19±63.53 45.08±82.72 58.36±90.64 0.138 0.205 0.197 0.406
ALP (U/L) 85.30±25.43 86.27±32.45 92.98±34.50 0.195 0.611 0.144 0.215
LDH (U/L) 168.99±47.07 159.14±34.27 167.78±39.07 0.001 <0.001 0.842 0.157
Total protein (g/L) 73.98±4.48 74.5±4.79 74.7±6.50 0.164 0.082 0.468 0.842
Albumin (g/L) 41.47±3.87 41.73±3.73 40.78±4.47 0.235 0.287 0.311 0.175
HbA1c (%) 5.20±0.43 5.27± 0.51 6.96±2.37 <0.001 0.024 <0.001 <0.001
HOMA-IR score 2.83±2.41 2.25±1.64 6.20±10.82 <0.001 <0.001 <0.001 <0.001
FPG (mmol/L) 5.09±0.42 5.2±0.56 8.34±5.17 <0.001 <0.001 <0.001 <0.001
TC (mmol/L) 5.2±1.04 5.24±1.30 5.39±1.15 0.492 0.581 0.278 0.419
TG (mmol/L) 1.33±0.79 1.74±1.29 1.49±1.00 <0.001 <0.001 0.304 0.124
LDL-C (mmol/L) 3.22±0.93 3.14±1.08 3.08±0.86 0.615 0.391 0.594 0.829
Hs-CRP (mg/L) 3.79±3.23 4.81±8.97 3.69±3.19 0.017 0.031 0.839 0.089
HDL-C (mmol/L) 1.34±0.33 1.27±0.49 1.52±0.57 <0.001 0.023 0.041 0.008
NFS score −2.44±1.36 −2.74±1.52 −2.22±1.66 0.001 <0.001 0.376 0.047
NFS score >-1.455, n (%) 154 (20.95) 72 (18.75) 16 (34.78) 0.040 0.428 0.043 0.019
FIB4 score 0.86±0.96 1.02±0.64 1.52±1.33 <0.001 <0.001 0.002 0.015
FIB-4 score >1.3, n (%) 99 (13.47) 90 (23.44) 18 (39.13) < 0.001 <0.001 <0.001 0.036

Abbreviations: MD, metabolic dysregulation; MAFLD, metabolic associated fatty liver disease; BMI, body mass index; NAFLD, non-alcoholic fatty liver disease; ALD, alcoholic liver disease; BUN, blood urea nitrogen; GFR, glomerular filtration rate; TBIL, total bilirubin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, γ-glutamyl transpeptidase; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; HbA1c, glycated hemoglobin; HOMA-IR score, homeostasis model assessment-insulin resistance; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; Hs-CRP, high-sensitivity serum C-reactive protein; NFS, NAFLD fibrosis score; FIB-4, fibrosis-4 index.